\
&
Contact us
\
&
Contact us
This was 9 months ago
LocationBrussels
There is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The Lithuanian RDI Liaison Office in Brussels (LINO) and Kaunas University of Technology (KTU) are organising an event to explore how research, AI, and digital technologies can address global challenges in sustainability and health. Highlights include discussions on AI-driven innovations, tools for early disease detection, and technologies supporting carbon-neutral living. A panel session will also provide practical insights on collaboration opportunities in European programmes, fostering impactful international partnerships.
Please find the event description and program attached for more details.
Registration is requested via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
Research Infrastructures Culture and society Climate, Energy, Mobility
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
